https://www.selleckchem.com/pr....oducts/Mycophenolic-
A total of 15 of 41 (37%) patients with dementia and 22 of 49 (45%) patients with delirium before initiation of Rotigotine inappropriately received the higher dose; 20 (24%) patients developed new/worsening delirium and 8 (10%) patients developed new/worsening hallucinations; and 59 (70%) patients were dead at time of evaluation, of these 40 (68%) died in hospital, 10 (25%) of whom experienced terminal agitation. acute conversion of oral dopaminergic medication to trans-dermal Rotigotine patch remains problemati
Like
Comment
Share
